Studies have shown that BDNF levels in AD patients decreased to a certain extent [55], whereas increasing the serum expression of BDNF prevented the occurrence of epilepsy and AD [55, 56, 61] and acute application of exogenous BDNF increased neuronal activity and synaptic transmission in cultured neurons [69]. This evidence concerns the gene BDNF and Alzheimer disease.